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Major histocompatibility complex class II antigens (MHC class II, Ia, murine
I-A and I-E, human HLA-DP, DQ, DR antigens), are expressed on cell surfaces
as noncovalently associated heterodimers. They consist of an a (34 kD) and a (3
(28 kD) chain. They act as restriction elements in both antigen presentation to
T cellsand in interactionsbetween T and B lymphocytes. MHC class II molecules
are constitutively expressed in B cells, T lymphoblasts, and some virally infected
T cells. Other cells do not express these determinants; however, their expression
can be induced by ,y interferon (IFN-'Y) in antigen presenting cells (APCs) (1, 2).
MHC class II genes have been investigated for the presence of cis-acting
regulatory elements. Atissue-specific transcriptional enhancerhas beendescribed
in the murine I-E# gene (3). Plasmid constructions containing a 2 kb 5' flanking
region of the I-E(3 gene transfected into a variety of cells increased the number
of stable transfectants when introduced into B lymphoma cells, but not when
introduced into la- Ltk- fibroblasts or plasmacytoma cells. When I-Ea genes
were introduced into I-Ea- mice, >1.4 kb of5' flanking I-Ea DNA was necessary
for tissue-specific and IFN--y-inducible expression of the transgene (4). Trunca-
tions ofthe 5' flanking DNA led to I-Ea expression in inappropriate tissues (5).
Previously, we reported on DNA methylation and chromatin structure of the
HLA-DRa gene, the human homologue of I-Ea gene (6). There was no corre-
lation between hypomethylation and HLA-DRa geneexpression. All cellsstudied
contained a hypomethylated CpG-rich island around the HLA-DRa promoter
and methylated 5' and coding/3' regions (6). However, we found differences in
the HLA-DRa chromatin structure. Cells not expressing HLA-DRa, including
those that could be induced with IFN-y, contained only one DNase I-hypersen-
sitive site, which mapped into the promoter region . In cells constitutively ex-
pressing HLA-DRa, two additional DNase I-hypersensitive sites were present.
These mapped into the first intron of the HLA-DRa gene and contained
sequences homologous to the core transcriptional enhancer elements, potential
topoisomerase II binding sites, and nuclear matrix-associated regions (7).
Here, we extend our studies on the chromatin structure of the HLA-DRa
gene . Fragments of the HLA-DRa gene were cloned into plasmid vectors
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containing the Herpes simplex thymidine kinase (tk)i promoter linked to the
bacterial chloramphenicol acetyltransferase (CAT) gene (8). These plasmid con-
structions were transfected into lymphoid and nonlymphoid cells. We show that
DNA fragments from the body ofthe HLA-DRa gene, which contain the intronic
DNase 1-hypersensitive sites, function as tissue-specific transcriptional enhancer
elements (9).
Materials and Methods
Plasmid Constructions. Plasmids pRSVCAT, pTEI, and pTEIAS/N (10); MSVp-
CAT3MSP and pCAT3MSP (11) have been described. pSP64-atkCAT is a plasmid
construction (CAT3MSP digested with Eco RI and Pvu 11 and the resulting 230 by
fragment ligated into Eco RI and Sma I sites of SP64) that can be transcribed with SP6
polymerase to yield the complementary strand to the 5' end of pCAT3MSP. Fragments
of the HLA-DRa gene were obtained from two different genomic clones, PDG019 (12)
and pH-6A (13). They were subcloned into pTEI or pTEIAS/N vectors at polylinker
sites. Constructions A, F2, G, H, and 11 were made by inserting the HLA-DRa subfrag-
ments into a polylinker site and into the Nru I site in plasmid pTEIAS/N. Therefore,
these clones do not contain the 598 by pBR322-derived fragment between the pTE1 Sal
I and Nru I sites. Plasmid constructions B, D, D, E, F1, and 12 were subcloned into the
polylinker sites of vector pTEI, which contains the 598 by pBR322-derived spacer. The
direction of HLA-DRa fragments A, B, C, D, E, F2, G, H, and 12, but not of fragments
F1, 11, with respect to HLA-DRa transcription is opposite to that of the tkCAT fusion
gene . Fragment I1 was also placed 3' of the CAT gene by inverting the tkCAT transcrip-
tional unit (excisable with Bam HI) in plasmid pTEIAS/N-I1 . Plasmids pCAT3MSP-GI
and G2 were constructed by ligating fragment G in both normal (GI) and opposite (G2)
orientations (with respect to HLA-DRa transcription) into the polylinker of vector
pCAT3MSP (see Fig. 1). All plasmids were prepared by two cycles of CsCl gradient
centrifugation .
Cell Culture and DNA Transfections. BJAB, Jurkat, and HUT-78 cells have been
described previously (7). Ltk- cells and HeLa cells were obtained from American "Type
Culture Collection, Rockville, MD. 2pk-3 is a murine B cell lymphoma (14). All adherent
cells were maintained in Dulbecco's modified Eagle's medium, whereas all nonadherent
cells were grown in RPMI-1640 medium (both from UCSF tissue culture facility),
supplemented with 10% FCS and antibiotics, at 37°C, in a humidified atmosphere
containing 95% air and 5% C02.
Nonadherent cells were transfected by the DEAE-dextran (Pharmacia Fine Chemicals,
Piscataway, NJ) procedure essentially as described (15). 3 x 107 cells were incubated in
1 .5 ml of 500 Ag/ml DEAE-dextran in TS buffer (8 g/liter NaCl, 0.38 g/liter KCI, 0.1
g/liter Na2HPO,-7H2)), 3 g/liter Tris-HCI, 0.1 g/liter MgC12, 0.1 g/liter CaCl2, pH 7.4)
containing 10 kg of supercoiled plasmid DNA for 20 min at room temperature. This
mixture was then diluted 10-fold with media containing 0 .1 mM chloroquine diphosphate
(Sigma Chemical Co ., St. Louis, MO) and incubated for an additional hour at 37°C. Cells
were centrifuged, washed once, resuspended in media, and grown for 48-60 h in the C02
incubator, after which CAT assays were performed and/or RNA isolated. Adherent cells
were transfected using the CaPO, procedure (16).
CATAssays and RNA Analysis.
￿
CAT assays were performed as described (17). After
48-60 h incubation, cells were lysed by three freeze-thaw cycles, and the lysates heated
for 5 min at 65°C (18). The lysates (0.125 M Tris-HCl, pH 7 .5) containing 1 mM acetyl
coenzyme A (Sigma Chemical Co.) were incubated at 37°C for 4 h in the presence of 0.2
,UCi of ['4C]chloramphenicol (Amersham Corp., Arlington Heights, IL). After thin-layer
chromatography, the silica plates were exposed to film and the l-acetyl and 3-acetyl
chloramphenicol spots were excised and counted in a liquid scintillation counter. All
' Abbreviationsused in this paper:
￿
CAT, chloramphenicol acetyl transferase; tk, thymidine kinase.WANG ET AL.
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transfections and CAT assays were repeated at least three times and standardized to
amounts of protein in the lysates.
RNA was isolated from transfected cells by the guanidinium isothiocyanate/CsCl
procedure (19). 50 jigoftotal RNA wasincubated with 106 cpmof ["P]UTP-labelled Eco
RI-linearized pSP64-atkCAT probe for 12 h in 80% formamide, 0.4 M NaCl, 20 mM
Tris-HCl (pH 7.0), 1 mM EDTA, and 0.1 % SIDS. The volume was increased 10-fold with
10 mM Tris-HCl (pH 7.5), 5 mM EDTA, 300 mM NaCl. RNase A (10 jig/ml final) and
T1 (1 jig/ml final) were added for 1 h at room temperature. The reactions were stopped
with SDS and proteinase K, organically extracted, ethanol precipitated, electrophoresed
on 6% urea-acrylamide sequencing gels, and autoradiographed as described (20).
Results
A Transcriptional Enhancer Is Found in theBody ofthe HLA-DRa Gene.
￿
To test
whether any part of the HLA-DRa gene can increase transcription from a
heterologous promoter, plasmid vectors containing elements of the HLA-DRa
gene fused to the tkCAT transcriptional unit were transfected into BJAB and
Jurkat cells. 48-60 h after transfection, cell lysates were prepared and assayed
for CAT enzymatic activity. BJAB are Ia+ human B cells, whereasJurkat are la-
human T cells. Their phenotypes were confirmed by Northern blot hybridization
using HLA-DRa cDNA probes. That the population of cells was homogeneous
was determined by FACS analysis of tissue culture cells labelled first with anti-Ia
monoclonal antibodies and second with fluoresceinated goat anti-mouse Ig
antiserum (data not shown) (7). Similar analyses were done for all other cells
used in this study.
The HLA-DRa sequences tested in this study are covered by fragments A (Pst
I/Xba 1; 2.5 kb), B (Xba I/Cla I; 1.8 kb), C (Bgl II/Hind III; 1,079 bp), D (Hind
III/Cla I; 3.8 kb), and E (Hind III/Hind 111; 2.5 kb) (see Fig. 1A). They span 7
kb of HLA-DRa DNA and extend from 2.8 kb upstream of the RNA cap site to
3.2 kb into the body of the gene. The CAT activity in cells transfected with
fragments A and E was baseline, but it was increased 2-18-fold with fragments
B, C, and D (Fig. 2 and Table I). Therefore, the DNA segments that comprise
the promoter, exon 1, and part of intron 1 contain transcription-enhancing
activity. Furthermore, fragments B and D, which contain all three elements,
resulted in three- to fivefold higher CAT activities than fragment C, which
contains only the intronic sequences, and fragment B was twofold more active
than fragment D (Table 1). In fragment D, HLA-DRa regulatory elements are
2 kb further upstream from the tk promoter than they are in fragment B.
Therefore, the reduction in CAT activity could be due to distance. However,
no differences in CAT activities were observed between constructions using the
pTE1 or the pTEIAS/N plasmid vectors (Table 1). Unlike pTE1AS/N, pTE1
contains a 598 by spacer derived from pBR322 between the tk promoter and
the polylinker into which HLA-DRa fragments were inserted. The pTE1
(tkCAT) control plasmid (without any insert to be tested) occasionally resulted
in weak and visually undetectable autoradiographic signals for the monoacety-
lated chloramphenicol spots (Fig. 2A, lane 4; Fig. 2, B and C, lane 3). However,
CAT activities were measured by counting excised spots in a liquid scintillation
counter. Here, the tk promoter could be shown to function in all cells and
resulted in comparable but low CAT enzymatic activities (Table I).
To map the cis-acting regulatory elements more precisely, we cloned DNA628
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FIGURE 1 .
￿
Schematic representation of the HLA-DRa constructions used in transient trans-
fection experiments. A: Theinformative restriction sitesandthe exons ofthe HLA-DRagene
are shown. Restriction endonucleases are: P, Pst I; H, Hind III; X, Xba I; S, Sac I; B, Bgl II ;
(,', Cla I. The direction of HLA-DRa transcription is from left to right. Fragments A-E, F1,
F2, G, H, 11, and 12 of the HLA-DRa gene were subcloned 5' or 3' to the tk promoter-
initiated CAT gene in the vectors pTEI or pTEIAS/N. The arrows indicate the orientation
of the HLA-DRa fragments relative to the tkCAT gene. Fragments are: A, Pst I/Xba I; B,
Xba I/Cla I; C, Bgl II/Hind III; D, Hind III/Cla I; E, Hind III/Hind III; F1 and F2, Xba
I/Bgl II: G, Sac I/Cla I; H, Sac I/Bgl II ; 11 and 12, Big II/Cla I. The activity of each fragment
is represented by symbols (+ or -) placed above the arrow denoting that fragment. B and C:
Fragments B-E, 12, and FI were cloned 5' ofthe tkCAT gene in thevector pTEI . Fragments
A, F2, G, H, and 11, were cloned 5' of thetkCAT gene in thevector pTEIOS/N. D: Fragment
II was cloned 3' of the tkCAT gene in the vector pTEIOS/N.
segments of fragment B into pTE1 or pTE10S/N plasmid vectors and obtained
fragments F (Xba I/Bgl II ; 1 kb), G (Sac I/Cla I; 1.5 kb), H (Sac I/Bgl 11 ; 750
bp), and I (Bgl II/Cla 1; 750 bp). All these fragments contained reproducible
transcriptional enhancing activities in BJAB and Jurkat cells; however, none of
them increased CAT activities as much as fragment B. Fragments F and H
increased CAT activities two- to threefold, and fragment I (from the middle of
intron 1) three- to sixfold, which is statistically significant (Fig. 2 and Table I) .
To further characterize the informative HLA-DRa intronic fragments F and
I, they were tested in both orientations 5' to the CAT gene, and in a selected
case, 3' to the CAT gene. In both orientations, these fragments resulted in
increased CAT activities in BJAB and Jurkat cells. Transfections with fragment
I resulted in consistently higher CAT activities than did those with fragment FWANG ET AL .
￿
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FIGURE 2 .
￿
Autoradiograph of CAT assays in BJAB (A), Jurkat (B), Ltk (C), and HeLa (D)
cells . Transfections and CAT assays were carried out as described in Materials and Methods .
A andB : lanes 1-5 represent transient transfections with pTEI-I2, pTEI AS/N-I 1, pTEI AS/N-
H, pTEI, and pRSVCAT, respectively. C and D : lanes 1-4 represent transient transfections
with pTEI-I2, pTEI-B,pTEI,and pRSVCAT, respectively . In A, above the 3-monoacetylated
chloramphenicol spots are seen contaminant bands found in some batches of commercially
available ['"C]chloramphenicol .
(Table I) . Fragment I also increased CAT activities in a position 3' to the CAT
gene in BJAB and Jurkat cells (Table I) .
The HLA-DRa Transcriptional Enhancer Functions in a Tissue-specific Man-
ner . To determine whether HLA-DRa cis-acting regulatory elements function
in a tissue-specific manner, the plasmid constructions that were positive in BJAB
and Jurkat cells were also tested in HUT-78, HeLa, and Ltk- cells . HUT-78 are
human la' T cells . HeLa are human endometrial carcinoma cells that are la- in
their resting state ; however, HLA-DRa expression can be induced with IFN-y .
Ltk- are la- murine fibroblasts . Fragments B and 12 increased CAT activities
20 and 6.5-fold in HUT-78 cells, but not in HeLaand Ltk- cells (Table I) . Thus,
fragments B and 12 function in lymphoid cells but not in human or murine630
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TABLE I
Relative Transcriptional Activities of DNA Fragmentsfrom the HLA-DRa Gene
Constructions
Relative CAT activity
￿
Chloramphenicol Conversion
BJAB Jurkat BJAB Jurkat
pRSVCAT
pTEI or pTEIAS/N
pTE10S/N-A
pTEI-B
pTEI-C
pTEI-D
pTEI-E
pTEI-FI
pTEIAS/N-F2
pTEIAS/N-G
pTE1 AS/N-H
pTEIAS/N-11
pTEI-12
pTE10S/N-3'11
pRSVCAT
pTEI or pTEI S/N
pTEI-B
￿
19.5±0.8 1.0±0.2 1.0±0.4
pTEI-12
￿
6.5±0.3 0.9±0.3 1.2±0.2
Relative CAT activities obtained with different plasmid constrictions in BJAB, Jurkat, HUT-78,
HeLa, and Ltk- cells. Cellsconstitutively expressing HLA-DR determinants are BJAB and HUT-78.
All transfections were repeated at least three times. Mean ± SD is shown. The ranges of percent
chloramphenicol conversion are given for BJAB andJurkat cells, and the mean percent chloram-
phenicol conversions are given for HUT-78, HeLa, and Ltk- cells. All CAT signals were normalized
to the number of cells transfected and to amount of total protein. pRSVCAT showed the strongest
signals in Jurkat and HUT-78 cells.
fibroblasts. We also tested the effects of IFN-y on these cis-acting regulatory
elements. IFN-y in concentrations of 100 IU/ml did not increase CAT activity
in HeLa cells transfected with fragments B and 12 (data not shown).
CAT Transcripts Initiate from the tk Promoter.
￿
To map the precise sites of
transcriptional initiation in these plasmid constructions, RNA was isolated from
transfected cells and assayed by RNase protection techniques. Because the level
of CAT-specific RNA was so low in transiently transfected human lymphoid cells
that it could not be detected with conventional techniques, the HLA-DRa
genomic fragments were cloned into vectors containing the polyoma early region
and the origin of replication. These constructions replicate in rodent cells,
yielding high copy numbers of intracellular plasmid DNA (21). After transient
transfection into murine 2pk-3 cells, which are Ia+ murine B cells, there is no
difference in the transcription initiation between tkCAT (pCAT3MSP)-,
MSVtkCAT (MSV-pCAT3MSP)-, and fragment G (pCAT3MSP-G1 and G2)-
containing plasmids (Fig. 3). However, the murine Moloney sarcoma virus (MSV)
transcriptional unit was weaker than the Rous sarcoma virus long terminal repeat
in these cells, and resulted in only moderately increased CAT activities and
170 257 32-44 45-60
1.0 1.0 0.1-0.30 0.1-0.45
0.7 ± 0.2 0.7 ± 0.3 0.05-0.2 0.05-0.3
10.3 ± 0.8 17.0 ± 1.3 1.0-4.0 2.0-8.0
2.1 ± 0.1 3.6 ± 0.4 0.4-0.7 0.4-1 .3
5.1 ± 0.4 7.8 ± 0.8 0.8-1 .6 1.0-3 .0
1.0±0.6 1.6±0.2 0.2 0.4
2.1 ± 0.1 2.2 ± 0.2 0.5-0.6 0.6-0.9
2.0 ± 0.2 2.3 ±0.4 0.5 0.8
3.9 ± 0.9 5.6 ± 0.1 0.8-1 .1 1.0-2.2
2.0 ± 0.1 2.6 ±0.1 0.6 0.7
3.6 ± 0.5 5.9 ± 0.5 0.7-1 .2 0.7-2.5
3.4 ± 0.8 5.4 ± 0.4 0.4-1 .2 0.6-2.0
2.4 ± 0.4 2.1 ± 0.3 0.3-0.5 0.3-0.8
HUT-78 HeLa Ltk- HUT-78 HeLa Ltk-
250 170 150 46.0 26.0 30.0
1.0 1.0 1.0 0.2 0.15 0.2WANG ET AL .
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FIGURE 3 . RNase protection analysis . Lanes 1-4
represent transient transfections into 2pk-3 cells
and with pCAT3MSP, pCAT3MSP-G,, G, and
MSVPCAT3MS plasmid constructions, respectively .
Size markers (on the right, in basepairs) arefrom end-
labeled Hae III-digested OX174 . The pSP64-
aTKCAT transcript protects a 200-by-long fragment
in all four lanes, which corresponds to initiation of
CAT transcription from the usual tk promoter cap
site .
transcripts compared with those with fragment G (Fig . 3 and data not shown) .
These data show that fragments from the body of the HLA-DRa gene increase
the levels of appropriately initiated CAT RNA.
DNA Sequences in Intron 1 Share Homologies With Other Eukaryotic Transcriptional
Enhancers . Within fragments F and I there are DNA sequences found in other
eukaryotic transcriptional enhancers (Fig . 4) . These have been described previ-
ously and consist of core transcriptional enhancer elements (9), octamer (22), A-
T-rich regions (23), and potential topoisomerase 11 sites (24), as well as nuclear
matrix-associated regions (25) . In addition, immunoglobulin switch consensus
(TGGGGG) (26)and 250 by Alu repeat sequences (27) are found . A diagramatic
representation of these sequence motifs is shown in Fig . 4 .
Discussion
The data presented map tissue-specific enhancer elements into the body of the
HLA-DRa gene . The largest transcriptional effects were observed with fragment
B, which contains theHLA-DRa promoter, exon 1, and part of intron 1 . When
this fragment was divided into smaller subfragments, fragment I from the middle
of intron 1 retained most of the activity . Fragment I increased transcription
from a heterologous promoter in an orientation- and position-independent
fashion . It functioned in lymphoid cells, but not in human or mouse fibroblasts .
Thus, fragment I satisfies the definition of a tissue-specific eukaryotic transcrip-
tional enhancer element (9). The adjacent fragmentH showed similarbut smaller
effects . The effects of fragments I and H are not additive, because fragment G,
which combines DNA sequences of fragments Hand I, resulted in CAT activities
similar to those of fragment I alone . However, intronic and promoter elements
must be multiplicative, because fragment B resulted in threefold higher CAT
activities than fragments G or I alone . Similar cooperativity has been found for632
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(S) CCTCACTCCCGAGCTCTACTGACTCCCAAAAGAGCGCCCAAGAAGAAAATGGCCATAAGTGGAGTCCCTGTGCTAG
GATTTTTCATCATAGCTGTGCTGATGAGCGCTCAGGAATCATGGGCTATCAAAGGTAGGTGCTGAGGGAATGAAATCTGG
GACGATAGACTACGAAGCATTGGAGAAAAGACCTATGGACATTTGGAAGATAATGTGTGGAGTGAAAGAATAGTGTGACA
GGTATTATGTGGTCTCGACAGAAAGTATAACAAACI'TGTGGTTTQOTGGAGTTCTTCCCTCACCACAAACTGAAGTAAGTC
AAATTTGGTTTAGAGGGTCAAAACTGAGTTGTGTATTGATGAATAGCACGGTCCTGCTACAAGCCAAACIrGGGGGTGGGG
GTGGGGGTGG
ATTAGTAAAATTAAAAACTAAAAACCACACATAGTTTTGTTAGAATTAAATGAAAAAAAAAGTTATTAGCCCTGTTCTTA
TCTGAATACATGATACAGTAGTTATTTTTTGGAGTGTAAATCCTGTC TATATATTGAGCA+ TATATTGTGTTGAAGA
TTACTAGAAGGAAAAGTCATCAAAAAGCAACAATTTACCCCAGGAAAAGGGGAGGGAAGGCATGCTGATATGAGTTGCCT
CATGGGACAGTGATAGCCATTCCCTGCCTTCCCATCTCCATGGTACAGC (B)
(B) AGATCTTATATCATGTTAACTTAGT TATT CAAGAGAGTAGAAAAATAAGTAAGGAAATGGGGAATCTGATAT
TATTGTCTCTCATCTCCAGAGCAACATTGGTGCTGTTGTAAAGATGTACTGTAGAAAAGTATTCTTCACCCAGCGTGACC
CCCACAGAAGGTGTCAGGTAGACTTGGAATAAGCAAAGTAATAACCCAGCTCCCATACCCATAGTGGCAATTGTAGATTT
CTATTGCCCCAAAAGAGCCATACATAGGGATACTTACCTAGAAAGACAGAGGATCTTQCCTTGGTTTMGAAGAGGCAGC
TAG
GGAAG TATT CTGGCAAGCATTAACAAGT TATT TGGGCTTTAATTATTCTTTCTGGAAA
ATAGATGGAAGTAAATAAATTCCTAGGTTTATCAATACAC 3TCAAACATTTAAAA
TCTCATCTTGGCTGGGCACGGTGGCTCACG*PAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAAGA
GATCGAGACCGTCCTGGGCAACATGGTGAAACCCCGTCTCTACTAAAATACAAAAAATTAGCTGGGTATGGTGGCACACG
CCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGGATTGCTTGGCCCGGGAGGCGGAGGTTGCAGTGAGCTGAGATG
GTGCCACTGCACTCCAGCCTGGCGATAGAGCAAGACTCCGTCTC AACCAAACCAAAACAAAAC TA TCACC
TTATCTTTGAAGACTAAGGAAAAAAAAAATCTCCCACTC (C)
FIGURE 4.
￿
A mapof the HLA-DRa gene. A: 8.0 kb of HLA-DRa DNA composed of 2.5 kb
of 5' flanking and 5.5 kb of coding information. S, B, and C standfor Sac I, Bgl II, and Cla I
restriction endonucleases. B: enlargement of thearea between Sal I and Cla I sites. II and III
denote DNase I-hypersensitive sites (7). Open squares denote exons andAlurepeat sequences.
Open circles denote positions of core transcriptional enhancer consensus elements. Dotted
squares representpotential topoisomerase Il bindingsites. Squareswith slanted lines represent
A-T-rich regions of DNA, and black arrows denote the locations ofATATTT sequences. The
square with horizontal lines denotes the location of the sequence TGGGGG repeated four
times. C: DNA sequences found between Sac I (S) and Cla I (C) sites marked as in B.
3'WANG ET AL.
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fragments of the immunoglobulin K gene, where the intronic transcriptional
enhancer and the promoter associated octamer result in transcriptional effects
which are multiplicative (11, 28, 29). It is of interest that an octamer in the
immunoglobulin K orientation is also found in the promoter of the HLA-DRa
gene . Thus, these regions flanking and including exon 1 form a transcriptional
unit that facilitates the tissue-specific transcription of the HLA-DRa gene.
Previously, we described DNase I-hypersensitive sites in the HLA-DRa gene
(7). In cells that do not express la determinants, and in those that can be induced
with the administration of IFN-,y, there is only one promoter associated DNase
]-hypersensitive site . However, in cells constitutively expressing high levels of
HLA-DRa, two additional DNase ]-hypersensitive sites were found in intron 1 .
One site maps into fragment I and the other into fragment H . Both contain
sequences found in other eukaryotic transcriptional enhancers. It is therefore
not surprising that these fragments function to increase transcription in lymphoid
cells. However, it is unexpected that they act in both B and T cells, even though
in resting T cells, HLA-DR a gene is not expressed, and Jurkat cells did not
contain the intronic DNase I-hypersensitive sites. The immunoglobulin heavy
chain transcriptional enhancer also functions in some T cells (30) . These anom-
alies may be particular to transient-expression assays, where the introduced
plasmid DNA does not reproduce the environment and the chromatin structure
of endogenous genes. Alternatively, T cells may contain trans-acting factors that
prevent initiation of HLA-DRa transcription . Recently, we have observed that
the upstream promoter elements block HLA-DRa transcription in Jurkat but
not in HUT-78 and BJAB cells (Peterlin, B. M., S. Y. Tsang, and M. Nakanishi,
manuscript in preparation) . Thus, the transcriptional enhancer elements in the
body of the HLA-DRa gene would still function, but transcription from the
promoter is blocked. In HeLa and Ltk- cells neither the transcriptional enhancer
elements nor the HLA-DRa promoter show detectable activity.
Both DNA sequences in fragments I and H contain core transcriptional
enhancer elements similar to the immunoglobulin « B element, which shows
tissue-specific protein-DNA interactions (31) . Fragment I also contains the
octamer, with one base mismatch, GTTTGCAT. Different orientations of the
octamer ATTTGCAT are found in the immunoglobulin and the HLA-DRa
promoters and in the immunoglobulin heavy chain enhancer (22). It also shows
tissue-specific DNA-protein interactions (23). In addition, potential topoisom-
erase II binding and cleavage sites, as well as A-T-rich regions that may form
nuclear matrix attachment sites are found in fragments H and I (23, 24) . Such
sequence motifs are found adjacent to the immunoglobulin «enhancer and may
introduce torsional stress into the chromatin loops of the HLA-DRa gene (24).
Different types of torsional stress are thought to help determine the transcrip-
tional activity of eukaryotic genes.
The comparison of the HLA-DRa cis-acting regulatory sequences with those
of the immunoglobulin genes invite speculation that some trans-acting factors
will be tissue specific. Some of these will bind DNA directly and will be revealed
by studies where proteins bound to DNA either retard gel migration of labeled
DNA fragments, or protect the underlying DNA sequences from chemical or
enzymatic degradation. These studies are now in progress. Because the HLA-634
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DRa transcriptional enhancers do not function in one distinct genetic comple-
mentation group of the MHC class I1-negative Raji cell mutants whereas they
do function in other independently derived mutants and in parental Raji cells,
we have designed direct genetic approaches to rescue the gene(s) coding for
HLA-DRa tissue-specific transcriptional enhancer trans-acting factors.
Summary
We mapped cis-acting regulatory elements in the HLA-DRa gene, which
encodes the monomorphic subunit of the HLA-DR heterodimer. Genomic
fragments of HLA-DRa were placed 5' or 3' to the chloramphenicol acetyltrans-
ferase reporter gene, the transcription of which was initiated from the Herpes
simplex thymidine kinase promoter. In transient expression assays, fragments
from the body of the HLA-DRa gene were able to increase chloramphenicol
acetyltransferase activity in a position-, orientation-, and promoter-independent
yet tissue-specific fashion . These HLA-DRa cis-acting regulatory elements con-
tain previously identified DNase 1-hypersensitive sites and DNA sequences
homologous to those found in other eukaryotic transcriptional enhancers.
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